BSE filing, NSE: SURYAROSNI. Summary written from the filing by ALFA Finder's alert engine.
Surya Roshni Ltd: key numbers
- Share price
- ₹208.65
- Market cap
- ₹4,541 Cr
- Revenue (annual)
- ₹7,540 Cr
- Net profit (annual)
- ₹285.8 Cr
- P/E (TTM)
- 14.6×Sector 16.9×
- Promoter holding
- 63.02%+0.00% QoQ
- FII holding
- 4.27%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Surya Roshni Ltd
All →Surya Roshni Other Announcement
Surya Roshni Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026, as required by regulatory norms.
Surya Roshni Business Update
Surya Roshni Ltd reported record quarterly sales volumes for Q2 FY27. Steel Pipes & Strips volume grew 23% YoY to 2.67 lakh tonnes.
- sales volume
- 2.67 lakh tonnes
Surya Roshni Annual General Meeting
Surya Roshni Ltd held its 53rd Annual General Meeting on September 15, 2026, transacting ordinary and special business items via video conferencing.
Surya Roshni Annual General Meeting
Surya Roshni Limited has issued the notice for its 53rd Annual General Meeting scheduled for September 15, 2026. The company also released its Annual Report for FY 2025-26.
Surya Roshni Earnings Call Transcript: Key Takeaways
Surya Roshni reported strong volume growth but faced EBITDA per ton pressure due to soaring ocean freight and input costs. Management remains optimistic about achieving long-term targets despite near-term logistics headwinds.
- Call
- Guides 23% growth
Surya Roshni Investor Presentation: Key Takeaways
Surya Roshni reported strong Q1FY27 results with 28% Revenue growth and 77% PAT growth, driven by record volumes in Steel Pipes and all-time high Lighting sales.
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.